REG - Ashington Innovation - Dual Listing on the Frankfurt Stock Exchange

Ashington InnovationAnnouncement

21/08/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230821:nRSU8349Ja&default-theme=true

RNS Number : 8349J  Ashington Innovation PLC  21 August 2023

Press Release

 

21 August 2023

 

Ashington Innovation plc

 

("Ashington" or "the Company")

 

Ashington Announces Dual Listing on the Frankfurt Stock Exchange

Ashington Innovation plc (LSE: ASHI), a special purpose acquisition company
("SPAC") established to acquire businesses primarily in the technology sector,
is pleased to announce that it has received approval for its ordinary shares
to commence trading on the Frankfurt Stock Exchange ("FSE") under the ticker
symbol "6FW". Ashington's FSE information can be found on the Börse Frankfurt
website: https://www.boerse-frankfurt.de/en
(https://www.boerse-frankfurt.de/en) .

 

The FSE is one of the world's largest international trading centres for
securities. Operated by the Deutsche Börse Group, FSE is the largest of
Germany's eight stock exchanges, and is responsible for approximately 90
percent of all securities traded in Germany. The FSE facilitates advanced
electronic trading, settlement and information systems and enables
cross-border trading for international investors.

 

Following the announcement of Ashington's proposed reverse takeover of Cell
Therapy ("the Transaction") on 17 August 2023, the Company's ordinary shares
are suspended pending the publication of a prospectus or an announcement that
the Transaction is not proceeding.

 

Jason Smart, Founder of Ashington, said: "We are thrilled to announce the
listing of our shares on the Frankfurt Stock Exchange. As one of the largest
exchanges in the world, our dual-listing will enhance trading liquidity and
facilitate investment in Ashington by institutional and retail investors
across Europe."

 

For further information please contact:

 

 Ashington Innovation plc
 David Orchard                       via Tancredi +44 207 887 7633

 General Counsel
 Tancredi Intelligent Communication

 Media Relations
 Helen Humphrey                      +44 7449 226 720

 Charlie Hobbs                       +44 7897 557 112

 Jasmine Gadhavi                     +44 7931 435 236

 ashington@tancredigroup.com

About Ashington Innovation plc

 

Ashington Innovation PLC is a special purpose acquisition company (SPAC),
formed with the intention of acquiring businesses operating in the technology
sector.

The Company believes that in the increasingly fast-changing global environment
there will be an abundance of opportunities to acquire existing businesses in
the technology sector, and in particular businesses that possess and utilise
proprietary technologies and own applicable intellectual property.

The Company is not limited to any specific geographic region in identifying
its target companies.

www.ashingtoninnovationplc.com (http://www.ashingtoninnovationplc.com) .

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCQVLFFXVLLBBZ